Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

17.650
+1.0506.33%
Volume:2.63M
Turnover:45.22M
Market Cap:18.73B
PE:-58.74
High:17.900
Open:16.600
Low:16.500
Close:16.600
52wk High:18.750
52wk Low:3.920
Shares:1.06B
HK Float Shares:1.06B
Volume Ratio:0.53
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.300
ROE:-12.77%
ROA:-12.32%
PB:8.85
PE(LYR):-58.74
PS:6994.67

Loading ...

Hong Kong Market Enters Era of Pricing Power Stratification as Mainland's 1.41 Trillion HKD Southbound Flows Anchor Market While Korean Retail Investors Ignite Speculative Activity

Stock News
·
Feb 13

Assessing Ascletis Pharma (SEHK:1672) Valuation After New Obesity And Acne Pipeline Updates

Simply Wall St.
·
Feb 11

Ascletis Pharma Selects Oral Weight-Loss Drug for Further US Studies

MT Newswires Live
·
Feb 11

BRIEF-Ascletis Pharma Selects Asc36 For Clinical Development

Reuters
·
Feb 11

Ascletis Pharma: Expects to Submit Ind to FDA for Asc36 Oral Tablets for Treatment of Obesity in Q2 2026

THOMSON REUTERS
·
Feb 11

Ascletis Pharma Inc. (1672) Announces Oral Amylin Receptor Peptide Agonist ASC36 for Clinical Development

Bulletin Express
·
Feb 11

ASCLETIS-B Selects Oral Amylin Receptor Agonist Peptide ASC36 for Clinical Development

Stock News
·
Feb 11

Ascletis Pharma Inc - Selects Asc36 for Clinical Development

THOMSON REUTERS
·
Feb 11

Ascletis Pharma Selects Oral Amylin Agonist ASC36 for Clinical Development

Reuters
·
Feb 11

Ascletis Pharma (01672) Announces 69.256 Million New Shares Issued and Provides Share Repurchase Update

Bulletin Express
·
Feb 10

Ascletis Pharma (1672) Announces Completion of New Share Placement Under General Mandate

Bulletin Express
·
Feb 10

ASCLETIS-B Completes Placement of 69.256 Million Shares, Raising Approximately HK$835 Million Net Proceeds

Stock News
·
Feb 10

Ascletis Pharma platziert 69,26 Millionen neue Aktien bei Investoren

Reuters
·
Feb 10

ASCLETIS-B (01672) Rises Over 6% Again as ASC30 Accelerates Global Phase III Trials; Analysts See High BD Potential

Stock News
·
Feb 10

HK Movers | HK's Biotech Shares Soar. ImmuneOnco up 7%; Zai Lab, Remegen, Innovent Bio up 5%; Ascletis, Wuxi Bio up 4%

Tiger Newspress
·
Feb 10

HK Movers | Ascletis Pharma Stock up 8% After GIC Invests US$100M in Company, Anchoring Long-Term Capital in China's Core Innovative Drug Assets

Tiger Newspress
·
Feb 09

ASCLETIS-B Shares Surge Nearly 9% in Morning Session Following GIC's HK$781 Million Stake Increase

Stock News
·
Feb 09

Tirzepatide Crowned as New "Blockbuster Drug King" with Rapid Commercial Value Release Expected for Weight Loss Medications

Stock News
·
Feb 05

Ascletis Pharma (SEHK:1672) Is Up 5.4% After HK$844m Follow-On Offering And Positive Phase III Acne Data - Has The Bull Case Changed?

Simply Wall St.
·
Feb 04

After Clearing Up Acne, Sagimet Stock Rises -- Barrons.com

Dow Jones
·
Feb 04